[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364982-105":59,"doc-detail-364982-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","liver-hepatocellular-carcinoma-lihc-study-on-scaf1-angiogenesis-and-immunomodulation","Liver hepatocellular carcinoma (LIHC) - Study on SCAF1, angiogenesis, and immunomodulation","","Liver hepatocellular carcinoma (LIHC) is a highly vascular malignancy with high incidence, difficult early detection, and poor prognosis. This study investigates SCAF1 as an immune-regulatory gene and potential driver of multiple LIHC mechanisms, including angiogenesis promotion and immunomodulation. Using TCGA-based WGCNA, enrichment analyses, immune exploration with TIMER and TISIDB, and spatial/single-cell work from GEO, the research assesses tumor microenvironment heterogeneity and performs molecular docking for pharmacological insight. Findings show SCAF1 upregulation is linked to worse survival and increased angiogenesis, invasion, and migration, while genistein suppresses SCAF1 and VEGFA.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/liver-hepatocellular-carcinoma-lihc-study-on-scaf1-angiogenesis-and-immunomodulation/364982/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/liver-hepatocellular-carcinoma-lihc-study-on-scaf1-angiogenesis-and-immunomodulation/364982.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main research focus of this study?","Question",{"text":113,"@type":114},"The study focuses on SCAF1’s role in liver hepatocellular carcinoma (LIHC), particularly its involvement in angiogenesis promotion and immunomodulation, and how these affect tumor progression and therapeutic outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the researchers identify SCAF1-related hub genes?",{"text":118,"@type":114},"The researchers obtained TCGA data and used Weighted Gene Co-expression Network Analysis (WGCNA) to explore hub genes, followed by functional identification using enrichment analysis.",{"name":120,"@type":111,"acceptedAnswer":121},"What experimental findings link SCAF1 to LIHC progression?",{"text":122,"@type":114},"SCAF1 is upregulated in LIHC and its higher expression correlates with decreased patient survival. Overexpression is associated with enhanced angiogenesis, invasion, and migration, and chemokine analysis indicates SCAF1 can inhibit factors such as CCL19.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364982,1790248366,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Nanchang University Second A¨liated Hospital  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nNanchang University-Qianhu Campus: Nanchang University  \nGuizhou Provincial People's Hospital  \nNanchang University Second A¨liated Hospital [https://orcid.org/0000-0001-9122-2976](https://orcid.org/0000-0001-9122-2976)  \nSCAF1, biomarker, liver hepatocellular carcinoma, angiogenesis, chemokine, pharmacology  May 29th, 2024  \n [https://doi.org/10.21203/rs.3.rs-4323231/v1](https://doi.org/10.21203/rs.3.rs-4323231/v1)  \n 􀁱 􀅏 This work is licensed under a Creative Commons Attribution 4.0 International License.  \nRead Full License  \nLiver hepatocellular carcinoma (LIHC) is a highly vascularized entity closely associated with immune functions, characterized by high incidence, elusive early detection, high malignancy, and poor prognosis. SCAF1 participates in the immune regulation mechanisms of various cancers (gliomas, breast cancer, etc.) and is involved in regulating the level of gene transcription. Nevertheless, there is currently no research focusing on the multiple mechanisms of SCAF1 in LIHC, including angiogenesis promotion and immunomodulation.  \nIn this study, we obtained TCGA data and utilized Weighted Gene Co-expression Network Analysis (WGCNA) to explore hub genes, followed by evaluating the prognostic and clinical signi¦cance of SCAF1 . Functional identi¦cation of SCAF1 in LIHC was performed through enrichment analysis. Subsequently, the immune therapeutic effects of SCAF1 were explored using TIMER and TISIDB. Spatial transcriptomics and single-cell sequencing analysis based on GEO data were conducted to assess heterogeneity tissue within the tumor microenvironment. Finally, molecular docking predictions were performed using Perl to evaluate pharmacological effects.  \nWe identi¦ed a signi¦cant upregulation of SCAF1 in LIHC, and its overexpression may lead to decreased patient survival rates, enhanced levels of angiogenesis, invasion, and migration capabilities in LIHC. Chemokine analysis results demonstrated that the up-regulation of SCAF1 expression could inhibit the expression of cell factors such as CCL19 . Experimental results demonstrated that genistein could downregulate SCAF1 and VEGFA in LIHC and inhibit cell invasion and migration levels.  \nSCAF1 can in§ uence angiogenesis in LIHC and affect tumor progression and therapeutic outcomes in LIHC patients through angiogenesis regulation.  \nLiver hepatocellular carcinoma (LIHC) is a solid tumor with poor prognosis and fast development due to its high vascularization [ 6, 7] . Its ¦ve-year survival rate is merely 20%[8] . Vascular endothelial growth factor (VEGF) is a signaling pathway capable of triggering downstream cellular pathways through phosphorylation cascades, ultimately leading to endothelial proliferation and migration. It is closely associated with tumor angiogenesis, rapid growth, and dissemination. The VEGF signaling pathway is collectively regulated by various angiogenesis-related factors. Among these VEGFs, VEGFA is produced  \nby tumor-associated macrophages (TAMs) and manipulates tumor cell invasion and migration by enhancing VEGFA signaling transduction and bioavailability [9, 10] .  \nAn increasing body of research indicates that numerous chemokines can modulate tumor angiogenesis levels [ 11] . Chemokines constitute a superfamily composed of small proteins capable of speci¦cally binding to downstream cell G-protein-coupled receptors, altering cell secretion activity, and thereby regulating various cellular functions. As a result, chemokines are widely inv","cbCaigAUsFSOhU93","https://ap.wps.com/l/cbCaigAUsFSOhU93","pdf",10214701,23,"English","# Background\n## LIHC angiogenesis and prognosis\n## Roles of VEGFA and chemokines (CCL19)\n## SCAF1 and tumor regulation\n# Methods\n## TCGA and WGCNA hub-gene analysis\n## Functional enrichment and immune evaluation (TIMER, TISIDB)\n## Spatial transcriptomics and single-cell analysis (GEO)\n## Molecular docking predictions\n# Results\n## SCAF1 upregulation and prognostic relevance\n## Effects on angiogenesis, invasion, and migration\n## Chemokine-related regulation (e.g., CCL19)\n## Genistein-related validation\n# Conclusion\n## SCAF1 influences LIHC progression and therapeutic outcomes","[{\"question\":\"What is the main research focus of this study?\",\"answer\":\"The study focuses on SCAF1’s role in liver hepatocellular carcinoma (LIHC), particularly its involvement in angiogenesis promotion and immunomodulation, and how these affect tumor progression and therapeutic outcomes.\"},{\"question\":\"How did the researchers identify SCAF1-related hub genes?\",\"answer\":\"The researchers obtained TCGA data and used Weighted Gene Co-expression Network Analysis (WGCNA) to explore hub genes, followed by functional identification using enrichment analysis.\"},{\"question\":\"What experimental findings link SCAF1 to LIHC progression?\",\"answer\":\"SCAF1 is upregulated in LIHC and its higher expression correlates with decreased patient survival. Overexpression is associated with enhanced angiogenesis, invasion, and migration, and chemokine analysis indicates SCAF1 can inhibit factors such as CCL19.\"}]","Liver hepatocellular carcinoma (LIHC) - Study on SCAF1, angiogenesis, and immunomodulation | PDF",1790159610,58,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f0069611141726f9b8c1363a4b6e341.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbfd46987b53485469209d1795ecb50a.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a292e860812e856737afa7ff8b614f63.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d06453a70e6c5adcb5ad779fb9798f8.webp",980,1268]